Jeito Capital becomes key investor in Alentis Therapeutics as part of $67 million Series B financing round
Jeito Capital becomes key investor in Alentis Therapeutics as part of $67 million Series B financing round Jeito Capital selects Alentis Therapeutics as its fifth investment since launching the fund Alentis is focused on the development of breakthrough treatments for fibrotic diseases and associated cancers Paris, France, 15 June 2021 – Jeito Capital (“Jeito”), a […]